Drug therapy in chronic heart failure
- PMID: 14654574
- PMCID: PMC1742875
- DOI: 10.1136/pmj.79.937.634
Drug therapy in chronic heart failure
Abstract
Chronic heart failure is widely recognised as a common and escalating problem that causes major disability and often shortens life. Diuretics and digoxin have formed the mainstay of treatment for many years. Clinical trials have demonstrated that angiotensin converting enzymes and beta-blockers, in selected patients, improve symptoms and reduce mortality. Angiotensin-II antagonists and spironolactone may also have a role in certain individuals. Newer pharmacological approaches to the management of this complex disease are being developed, but await full evaluation.
Comment in
-
Drug therapy in chronic heart failure.Postgrad Med J. 2004 Apr;80(942):247. Postgrad Med J. 2004. PMID: 15082857 Free PMC article. No abstract available.
-
Drug therapy in chronic heart failure.Postgrad Med J. 2004 Apr;80(942):247. Postgrad Med J. 2004. PMID: 15082858 Free PMC article. No abstract available.
-
Looking beyond haemodynamics in chronic heart failure.Postgrad Med J. 2004 Apr;80(942):247. Postgrad Med J. 2004. PMID: 15082860 Free PMC article. No abstract available.
Similar articles
-
Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.J Am Geriatr Soc. 1997 Jul;45(7):809-12. doi: 10.1111/j.1532-5415.1997.tb01506.x. J Am Geriatr Soc. 1997. PMID: 9215330
-
Drugs for chronic heart failure.Med Lett Drugs Ther. 1999 Jan 29;41(1045):12-4. Med Lett Drugs Ther. 1999. PMID: 9949763 No abstract available.
-
Drug therapy of heart failure in the elderly.Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):235-42. doi: 10.1111/j.1076-7460.2003.02013.x. Am J Geriatr Cardiol. 2003. PMID: 12888704 Review.
-
Halting the progression of heart failure: finding the optimal combination therapy.Cleve Clin J Med. 2002 Feb;69(2):104-5, 109-10, 112. doi: 10.3949/ccjm.69.2.104. Cleve Clin J Med. 2002. PMID: 11990640 Review.
-
[Current problems of pharmacotherapy--heart failure].Ther Umsch. 1990 Aug;47(8):686-92. Ther Umsch. 1990. PMID: 1977205 German.
Cited by
-
Global mapping of interventions to improve the quality of life of patients with cardiovascular diseases during 1990-2018.Health Qual Life Outcomes. 2020 Jul 29;18(1):254. doi: 10.1186/s12955-020-01507-9. Health Qual Life Outcomes. 2020. PMID: 32727479 Free PMC article. Review.
-
Protective effect of oxymatrine on chronic rat heart failure.J Physiol Sci. 2011 Sep;61(5):363-72. doi: 10.1007/s12576-011-0154-y. Epub 2011 Jun 22. J Physiol Sci. 2011. PMID: 21691940 Free PMC article.
-
Approach to cardiovascular disease prevention in patients with chronic kidney disease.Curr Treat Options Cardiovasc Med. 2012 Aug;14(4):391-413. doi: 10.1007/s11936-012-0189-2. Curr Treat Options Cardiovasc Med. 2012. PMID: 22660924
-
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure.Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9607-12. doi: 10.1073/pnas.0500353102. Epub 2005 Jun 22. Proc Natl Acad Sci U S A. 2005. PMID: 15972811 Free PMC article.
-
Relationship Between Symptom Burden and Self-Management Among Patients with Chronic Heart Failure: A Cross-Sectional Study.Patient Prefer Adherence. 2023 Aug 7;17:1909-1921. doi: 10.2147/PPA.S419796. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37577359 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical